12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant movements. SINTX Techs (SINT) saw the largest gain, with shares up 79.8%, while Applied DNA Sciences (APDN) had the largest decline, dropping 30.0%. Other notable gainers include Phio Pharma (PHIO), Trinity Biotech (TRIB), NexImmune (NEXI), Vicarious Surgical (RBOT), and Longeveron (LGVN). On the losing side were Innovative Eyewear (LUCY), Synaptogenix (SNPX), DermTech (DMTK), Assure Holdings (IONM), and OpGen (OPGN).
January 31, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Applied DNA Sciences shares fell by 30.0% to $0.42, with a market cap of $5.7 million.
The significant drop in Applied DNA Sciences' share price could indicate negative sentiment or a reaction to recent news, likely leading to a short-term negative impact on the stock.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Innovative Eyewear's stock decreased by 17.45% to $0.35, with a market cap of $4.5 million.
Innovative Eyewear's pre-market decline suggests potential bearish sentiment that could persist in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Synaptogenix shares dropped by 13.74% to $0.19, with a market cap of $3.8 million.
The pre-market drop for Synaptogenix may reflect negative investor sentiment, potentially leading to further short-term declines.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Phio Pharma's stock increased by 34.21% to $0.79, with a market cap of $3.6 million.
Phio Pharma's significant pre-market rise indicates strong investor interest, which may lead to further short-term gains.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
SINTX Techs shares soared by 79.8% in pre-market trading, with a market cap of $2.2 million.
The substantial pre-market gain for SINTX Techs suggests positive investor sentiment which could lead to a short-term price increase if the momentum continues post-market open.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Trinity Biotech shares increased by 25.13% to $0.54, with a market cap of $20.7 million.
The pre-market gain for Trinity Biotech may attract investor attention and could lead to a short-term uptrend.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85